SCHEMBL6350424

SCHEMBL6350424

O=c1[nH]c2ccccc2c(-c2cccc(-c3ccccc3)c2)c1C1=CCCS1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.43
FASN P49327 1/20 0.41
PDE9A O76083 2/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
MAPK14 Q16539 2/20 0.38
HPGD P15428 3/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
MMP13 P45452 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
PADI4 Q9UM07 2/20 0.36
KDM4E B2RXH2 4/20 0.36
CTSV O60911 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10146697 0.88 FASN (0.46) FASNCDK5CDK5R1MAPK14HPGD
SCHEMBL6352443 0.82 MAPK14 (0.43) CDK5CDK5R1MAPK14PADI4
SCHEMBL6351855 0.81 PADI4 (0.50) MAPTMAPK1HTTPADI4MEN1
SCHEMBL957899 0.74 PDE2A (0.53) MAPTFASNPDE9ACDK5CDK5R1
SCHEMBL28132803 0.71 MAPT (0.71) MAPTPDE9ACDK5CDK5R1MAPK14
SCHEMBL962621 0.68 PDE2A (0.55) CDK5CDK5R1MAPK14MMP2MMP9
SCHEMBL6825380 0.64 MAPT (0.65) MAPTFASNPDE9ACDK5CDK5R1
SCHEMBL935270 0.64 PDE2A (0.48) MAPTPDE9ACDK5CDK5R1MAPK14
SCHEMBL20227594 0.63 PARP1 (0.63) MAPTPDE9AHPGDMAPK1HTT
SCHEMBL21636104 0.63 PARP1 (0.63) MAPTPDE9AHPGDMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115885-A1 Quinolinone PDE2 Inhibitors MERCK SHARP & DOHME LLC 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115885-A1 Quinolinone PDE2 Inhibitors PDE12, PDE2A, PDE4A MAPT 1502/4885FASN 3427/4885PDE9A 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.